Contact
searchSearch
HMP Global
Login

May 2016

From the Field
Mock Clinical Pathways: A Method for Exploring the Oncology Clinical Pathway Development Process
05/06/2016
Bing-E Xu, PhD; Bruce A. Feinberg, DO; Monica Lingam, MS
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...
Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...
...
05/06/2016
Journal of Clinical Pathways
Research Reports
Cost-Effectiveness of Afatinib Versus Erlotinib in the First-line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer With EGFR Exon 19 Deletion Mutations
05/06/2016
Rakesh Luthra, MS; Jonathan Graham, BS; Stephanie Earnshaw, PhD; Rohit Borker, PhD; Jonathan Lim, BS, MS, MSc
Abstract: A decision model was developed to compare the cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) with epidermal...
Abstract: A decision model was developed to compare the cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non–small cell lung cancer (NSCLC) with epidermal...
...
05/06/2016
Journal of Clinical Pathways
Counterpoint
Keeping Cures on the Shelf
05/06/2016
George Dahlman
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...
Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...
...
05/06/2016
Journal of Clinical Pathways
Viewpoint
Chemotherapy Shortages: When is Enough, Enough?
05/06/2016
Yoram Unguru, MD, MS, MA
Shortages of life-saving chemotherapy agents and supportive care drugs have presented physicians treating children with cancer with difficult decisions regarding drug allocation and prioritization. Guidelines...
Shortages of life-saving chemotherapy agents and supportive care drugs have presented physicians treating children with cancer with difficult decisions regarding drug allocation and prioritization. Guidelines...
...
05/06/2016
Journal of Clinical Pathways
Pharma Insights
Companion Diagnostics and Complementary Diagnostics in Clinical Practice: Better Medicine or Competitive Disadvantage?
05/06/2016
David Parker, PhD; Larry Blandford, PharmD
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out...
We are pleased to present the second installment in our recurring column, Pharma Insights. This month we take a look at an interesting twist in how the use of complementary and companion diagnostics is playing out...
We...
05/06/2016
Journal of Clinical Pathways
Clinical Pathways GPS
Hitting Each Component of the Triple Aim Along the Clinical Pathway
05/06/2016
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD; Seth Gordon, MBA; Scott Guerin, PhD
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
The concept of the Triple Aim—improving the experience of care, reducing the costs of care, and improving the health of populations—is increasingly becoming important to drug manufacturers, who must demonstrate how...
The...
05/06/2016
Journal of Clinical Pathways
Interview
An Alliance to Reform the Current Health Care System
05/06/2016
Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...
Enacted in March of 2010, the Affordable Care Act (ACA) aimed to provide Americans with better health security through comprehensive health insurance reforms.1 Since then, the ACA has helped to significantly reduce...
...
05/06/2016
Journal of Clinical Pathways
Research in Review
Elements for Successful Clinical Pathway Development and Maintenance Identified
05/06/2016
As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...
As pathways become more ingrained in the everyday care of patients with various diseases, Andrew R Bunchert, MD, and Gabriella A Butler, MSN, RN, health care professionals at the Children’s Hospital of Pittsburgh...
As...
05/06/2016
Journal of Clinical Pathways
Research in Review
Increasing Use of Percutaneous Liver Biopsy Accompanied by Growing Costs
05/06/2016
A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising...
A study of image-guided percutaneous liver biopsy (PLB) in patients with hepatocellular carcinoma has found that the procedure is increasingly being used in recent years despite safety concerns as well as rising...
A...
05/06/2016
Journal of Clinical Pathways
Research in Review
FACT-B Most Effective Health-Related Quality of Life Instrument for Breast Cancer
05/06/2016
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
Results from a study evaluating different tools intended to measure patient-reported health-related quality of life (HRQoL) in patients with breast cancer suggest that the Functional Assessment of Cancer...
...
05/06/2016
Journal of Clinical Pathways
Research in Review
Clinical Pathways Improve Outcomes and Decrease Costs in Pediatric Care
05/06/2016
The implementation of evidence-based, standardized clinical pathways may be an effective way of maintaining high-quality care at lower costs in pediatric care settings, results of a recent study show. Clinical...
The implementation of evidence-based, standardized clinical pathways may be an effective way of maintaining high-quality care at lower costs in pediatric care settings, results of a recent study show. Clinical...
The...
05/06/2016
Journal of Clinical Pathways
Research in Review
Hormone Therapy More Cost-Effective Than Chemotherapy for Patients With HR+/HER2- Metastatic Breast Cancer
05/06/2016
A study of patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) metastatic breast cancer has found that treatment with first-line chemotherapy offers no survival...
A study of patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR+/HER2–) metastatic breast cancer has found that treatment with first-line chemotherapy offers no survival...
A...
05/06/2016
Journal of Clinical Pathways
Research in Review
NCCN-Recommended Therapy for Ovarian Cancer Currently Underused in Medicare Patients
05/06/2016
A look at more than 10 years of data has shown that many patients with ovarian cancer covered by Medicare are not receiving treatment consistent with National Comprehensive Cancer Network (NCCN) recommendations,...
A look at more than 10 years of data has shown that many patients with ovarian cancer covered by Medicare are not receiving treatment consistent with National Comprehensive Cancer Network (NCCN) recommendations,...
A...
05/06/2016
Journal of Clinical Pathways
Editor's Page
For Buy-In of the Clinical Pathways Concept, Transparency Is Key
05/06/2016
Winston Wong, PharmD
Essential to the success of clinical pathways is transparency of the development process. This includes transparency regarding the clinical evidence reviewed, the economic evaluations made, and the process by which...
Essential to the success of clinical pathways is transparency of the development process. This includes transparency regarding the clinical evidence reviewed, the economic evaluations made, and the process by which...
...
05/06/2016
Journal of Clinical Pathways
JCP Nov-Dec Cover

Current Issue

December 2025
Volume 11
Issue 6
Current Issue
Issue Archive

Special Reports

Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
08/15/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
08/15/2025
Journal of Clinical Pathways
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
08/15/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
08/15/2025
Journal of Clinical Pathways
Special Report
Navigating the Management of Metastatic Colorectal Cancer in the Advanced Treatment Setting: Insights From an Expert Panel
06/12/2025
Tanios Bekaii-Saab, MD, FACP; Stacey Cohen, MD; Marwan Fakih, MD; Anwaar Saeed, MD
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the current treatment landscape and unmet needs in metastatic colorectal cancer (mCRC).
Review a special report on the...
06/12/2025
Journal of Clinical Pathways
Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

May 2016 Volume 2

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use